Scopolamine Market Estimated to Witness High Growth Owing to Increasing Demand for Treating Motion Sickness

 

Scopolamine Market 

Scopolamine is an anticholinergic alkaloid drug derived from plants in the Solanaceae family, primarily Scopolia and Datura. It is commonly used for treating motion sickness in the form of transdermal patches, tablets and injections. Scopolamine patches work by blocking signals in the brain that cause nausea and vomiting. It is especially popular among cruise passengers, train travelers and those prone to car sickness.

The global scopolamine market is estimated to be valued at US$ 3676.85 Bn in 2023 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

The scopolamine market is expected to witness high growth owing to increasing demand for effective treatments for motion sickness. According to the American Motion Sickness Foundation, around 80% of people experience motion sickness at some point in their lives. Prolonged journeys by ship, trains and road travel enhance the risk, which is a key factor driving sales of scopolamine patches and tablets. Moreover, growing popularity of cruises among vacationers across regions such as North America and Europe is further propelling market growth. Scopolamine offers a safe and convenient solution to prevent nausea and vomiting caused by motion. However, potential side effects such as dry mouth, blurred vision and drowsiness with high doses limit its adoption. Ongoing research to develop newer delivery forms with fewer side effects can present lucrative opportunities over the forecast period.

SWOT Analysis

Strength: Global Scopolamine Market Demand has wide applications in treating motion sickness and postoperative nausea & vomiting which are common problems faced by many individuals. The drug is also effective in controlling symptoms associated with Parkinson's disease. Scopolamine patches provide long-lasting relief from nausea for around 3 days with just one application making it a convenient treatment option.

Weakness: Scopolamine can cause severe side effects like blurred vision, constipation, dizziness, drowsiness in some patients. Prolonged use may lead to dependency. It crosses the blood-brain barrier easily which may lead to anticholinergic toxicity in accidental overdose cases.

Opportunity: Increasing incidence of Parkinson's disease globally due to aging population presents an opportunity to boost scopolamine sales. Growing demand for minimally invasive drug delivery systems like patches and gels is opening new growth avenues. Emergence of combination therapies using scopolamine with other antiemetics can help expand its market reach.

Threats: Availability of alternative antiemetic drugs like ondansetron and metoclopramide poses competition in certain application areas. Patent expiry of major scopolamine drugs enables entry of generic versions impacting prices of branded products. Rising R&D investments of pharmaceutical companies in development of novel nausea-relieving therapies can threaten scopolamine market share in long run.

Key Takeaways

The global scopolamine market is expected to witness high growth at a CAGR of 4.8% during the forecast period of 2023 to 2030. By 2030, the market size is projected to reach US$ 3676.85 Billion.

Regional analysis: North America dominates the scopolamine market currently owing to growing incidence of nausea & vomiting related conditions, high healthcare expenditure and availability of advanced treatments. The Asia Pacific region is expected to emerge as the fastest growing regional market in future driven by increasing Parkinson's prevalence, rising medical tourism and growing demand for Western medicines to treat lifestyle disorders.

Key players: Key players operating in the scopolamine market are Baxter International Inc., GlaxoSmithKline plc, Novartis AG, Perrigo Company plc. Scopolamine products offered by these companies include transdermal patches and injections indicated for motion sickness, postoperative nausea & vomiting and Parkinson's disease symptoms management.

Get more insights on this topic: https://www.insightprobing.com/scopolamine-market-growth-market-size-share-analysis/

Comments

Post a Comment

Popular posts from this blog

The Bladder Liners Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Urinary Incontinence

Image
  Bladder Liners Market Market Overview: Benzodiazepines are a class of psychoactive drugs belonging to the benzodiazepine family. These drugs are prescribed for various medical conditions such as anxiety disorders, panic disorders, insomnia, seizures, alcohol withdrawal syndrome, muscle spasms, and as an anesthesia aid. Some common examples of benzodiazepines include alprazolam, clonazepam, diazepam, and lorazepam. These drugs work by increasing the action of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the central nervous system. Due to their calming properties, they are widely used to treat insomnia, anxiety, panic attacks, agitation, seizures, muscle spasms, and alcohol withdrawal. Market Dynamics: The Benzodiazepine Drugs Market is primarily driven by the rising prevalence of anxiety disorders worldwide. As per Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S., affecting nearly 40 million adul
Read more

The Global Electric Powertrain Market Poised for Growth Driven by Sustainable Transportation

Image
  Electric Powertrain Market The global electric powertrain market is seeing rapid adoption as consumers seek more environmentally friendly transportation options. Electric powertrains offer much lower operating costs than internal combustion engines while also being more energy efficient with fewer moving parts. Battery electric vehicles and hybrids containing electric motors and batteries are able to deliver torque instantly for smooth acceleration and regenerative braking that captures kinetic energy to charge the batteries while slowing down. Automakers are developing advanced powertrain technologies that combine smaller, lighter electric motors with improved batteries capable of longer ranges between charges. The global Electric Powertrain Market is estimated to be valued at US$ 94.12 Mn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the majo
Read more

Poultry Market is Expected to be Flourished by Growing Demand for Protein-Rich Food

Image
Poultry Market The poultry market comprises farming of domesticated birds such as chickens, ducks, turkeys, and geese, primarily for their meat and eggs. Poultry meat is one of the most consumed meats globally owing to its high protein content. Chicken is the most commonly produced meat worldwide, with over 95 million tons produced annually. Poultry farming provides affordable animal protein to consumers while generating income and employment for farmers and allied industries. The global poultry industry includes large integrated production facilities, small commercial farms, and backyard flock operations. Technological advancements have increased efficiency in breeding, hatching, feeding, housing, and disease control. The global poultry market is estimated to be valued at US$ 15.88 billion in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key driv
Read more